Compare Sana Biotechnology Inc (SANA) vs Southern Copper Corp (SCCO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sana Biotechnology Inc vs Southern Copper Corp — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $873.84M), while Southern Copper Corp trades at $188.2 (market cap $146.07B). The key difference: Southern Copper Corp is far larger — about 167.2× Sana Biotechnology Inc's market cap, and Southern Copper Corp pays a 2.28% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| SANA | SCCO | |
|---|---|---|
Market Cap | $873.84M | $146.07B |
Sector | Health | Basic Materials |
52-Week High | $5.92 | $218.85 |
52-Week Low | $2.68 | $90.54 |
Enterprise Value | $848.03M | $148.12B |
Dividend Yield | — | 2.28% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SANA Biotechnology trades at $3.14, down 0.32% with a bearish technical signal. The company shows negative profitability metrics with ROE at -147.41% and net income of -$244.17M for 2025, though cash burn is projected to improve significantly in 2026. Recent positive developments include NEJM publication of groundbreaking diabetes data and multiple conference presentations highlighting clinical progress.
While analyst sentiment remains strongly bullish (82% buy ratings), the stock faces fundamental challenges with significant losses and high P/B ratio of 7.33. Investment opportunity lies in clinical pipeline advancements, but risks include ongoing cash burn and execution challenges in bringing therapies to market.
SCCO trades at $188.01, up 9.0% today, with a neutral technical signal and strong fundamentals including a 34.13% net income margin and robust cash flow. Recent earnings beats and positive news on copper demand from AI data centers highlight growth potential, though the stock trades above the consensus price target of $152.79.
Outlook is mixed: strong profitability and sector tailwinds support upside, but high valuation ratios and analyst caution pose risks. Investors should weigh earnings consistency against premium pricing and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →About Southern Copper Corp
Southern Copper Corp is an integrated producer of copper and other minerals and operates the mining, smelting, and refining facilities in Peru and Mexico. Its production includes copper, molybdenum, zinc, and silver. The company operates through the following segments: Peruvian operations, Mexican open-pit operations, and Mexican underground mining operations. Southern Copper generates the majority of its revenue from the sale of copper and the rest from the sale of non-copper products, such as molybdenum, silver, zinc, lead, and gold. Its geographical segments are The Americas, Europe, and Asia.
Read more on SCCO →
